Display options
Share it on

J Community Med Health Educ. 2012;2. doi: 10.4172/2161-0711.1000152.

Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the US-Mexico border: a qualitative study.

Journal of community medicine & health education

Patricia Chalela, José A Pagán, Dejun Su, Edgar Muñoz, Amelie G Ramirez

Affiliations

  1. Institute for Health Promotion Research, The University of Texas Health Science Center at San Antonio, 7411 John Smith Drive, Suite 1000, San Antonio, TX 78229.
  2. Department of Health Management and Policy, School of Public Health, University of North Texas Health Science Center, 3500 Camp Bowie Blvd. Fort Worth, TX 76107.
  3. Department of Sociology, The South Texas Border Health Disparities Center, University of Texas-Pan American, 1201 West University Drive, Edinburg, TX 78539.
  4. Institute for Health Promotion Research, The University of Texas Health Science Center at San Antonio, 7411 John Smith Drive, Suite 1000, San Antonio, TX 78229, .

PMID: 25473590 PMCID: PMC4248355 DOI: 10.4172/2161-0711.1000152

Abstract

BACKGROUND: Genetic testing for breast cancer may facilitate better-informed decisions regarding cancer prevention, risk reduction, more effective early detection, and better determination of risk for family members. Despite these potential benefits, significant portions of the US population-particularly Latinas-lack awareness of genetic testing for breast cancer susceptibility. Among women who are tested, less than 4% are Latina. To uncover reasons for Latinas' low participation, this study explores awareness, attitudes and behavioral intentions to undergo genetic testing among average-risk Latinas along the Texas-Mexico border.

METHODS: Eight focus groups were conducted with 58 Latinas aged 19-69 living in Hidalgo County, a largely Latino region of South Texas. Focus group discussions were digitally recorded, transcribed and analyzed using qualitative content analysis to assess, categorize and interpret them. Two experienced study team members analyzed transcripts to identify major concepts grouped into theme categories.

RESULTS: Participants mostly had less than a high-school education (43%), spoke primarily Spanish (52%), were of Mexican-American origin (90%) and had a family income of $30,000 or less (75%). Focus groups found that most participants had positive attitudes and strong interest in genetic testing, yet lacked general awareness and knowledge about genetic testing, its risks, benefits, and limitations. Participants also identified several key cultural-based influencers, such as family, religious beliefs and fear of testing.

CONCLUSION: The delivery of culturally adapted risk information is needed to increase and ensure Latinas' understanding of breast cancer genetic testing during their decision-making processes. Key Latino values-religiosity, importance of family and the influential role of health care providers in health decisions-should also be considered when designing interventions targeting this specific group. Further research is needed to identify effective ways to communicate genetic risk susceptibility information to Latinas to help them make informed testing decisions.

Keywords: Attitudes; Border; Breast Cancer; Focus Groups; Genetic Testing; Intentions; Latinas

References

  1. J Clin Oncol. 2003 Jun 15;21(12):2397-406 - PubMed
  2. Genet Test. 1997;1(2):91-8 - PubMed
  3. Breast Cancer Res Treat. 2010 Dec;124(3):643-51 - PubMed
  4. J Nutr Educ Behav. 2002 Jul-Aug;34(4):224-30 - PubMed
  5. Ann Intern Med. 2005 Sep 6;143(5):355-61 - PubMed
  6. J Nurs Scholarsh. 2006;38(2):126-32 - PubMed
  7. Genet Test. 2004 Spring;8(1):31-43 - PubMed
  8. J Community Genet. 2011 Dec;2(4):211-21 - PubMed
  9. Community Genet. 2003;6(3):147-56 - PubMed
  10. Cancer. 2009 May 15;115(10):2222-33 - PubMed
  11. JAMA. 2004 Jul 28;292(4):442-52 - PubMed
  12. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):618-23 - PubMed
  13. Genet Test. 2006 Summer;10(2):139-45 - PubMed
  14. Genet Test. 2001 Fall;5(3):193-200 - PubMed
  15. Med Decis Making. 2009 Mar-Apr;29(2):157-66 - PubMed
  16. Cancer. 1996 Jun 1;77(11):2318-24 - PubMed
  17. J Genet Couns. 2010 Dec;19(6):618-29 - PubMed
  18. J Clin Oncol. 2010 Feb 10;28(5):893-901 - PubMed
  19. Cancer Res. 2012 May 1;72 (9):2304-13 - PubMed
  20. JAMA. 2005 Apr 13;293(14):1783-5 - PubMed
  21. J Clin Oncol. 2002 Mar 15;20(6):1480-90 - PubMed
  22. J Genet Couns. 2010 Jun;19(3):255-68 - PubMed
  23. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1615-20 - PubMed
  24. Prev Med. 2000 Feb;30(2):155-66 - PubMed
  25. Am J Prev Med. 2009 Dec;37(6):524-30 - PubMed
  26. Genet Test. 2005 Spring;9(1):48-53 - PubMed
  27. J Clin Oncol. 2009 Dec 10;27(35):5887-92 - PubMed
  28. Nature. 2012 Apr 18;486(7403):346-52 - PubMed
  29. J Genet Couns. 2009 Feb;18(1):60-71 - PubMed
  30. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1666-71 - PubMed
  31. Ethn Dis. 2006 Spring;16(2):398-403 - PubMed
  32. Health Serv Res. 2011 Jun;46(3):859-76 - PubMed
  33. Patient Educ Couns. 2003 Nov;51(3):217-27 - PubMed
  34. Res Nurs Health. 2000 Aug;23(4):334-40 - PubMed
  35. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):96-102 - PubMed
  36. J Clin Oncol. 2006 May 10;24(14):2197-203 - PubMed
  37. Res Nurs Health. 2010 Feb;33(1):77-84 - PubMed
  38. JAMA. 2007 Dec 26;298(24):2869-76 - PubMed
  39. Genet Med. 2010 Feb;12(2):105-15 - PubMed

Publication Types

Grant support